Thrombolytic Therapy Market in Southeast Asia - Industry Outlook and Forecast 2020-2026

April 2020 | 91 pages | ID: T8BAC49E3F70EN
Market Monitor Global

Abstracts

The thrombolytic therapy market covers drug treatment, surgical treatment, etc. The typical players include Roche, Taj Pharmaceuticals, Genentech, etc.

This report contains market size and forecasts of Thrombolytic Therapy in Southeast Asia, including the following market information:
Southeast Asia Thrombolytic Therapy Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in Southeast Asia Thrombolytic Therapy Market 2019 (%)
The global Thrombolytic Therapy market was valued at 32090 million in 2019 and is projected to reach US$ 34740 million by 2026, at a CAGR of 2.0% during the forecast period. While the Thrombolytic Therapy market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Thrombolytic Therapy businesses, with lots of challenges and uncertainty faced by many players of Thrombolytic Therapy in Southeast Asia.
This report also analyses and evaluates the COVID-19 impact on Thrombolytic Therapy market size in 2020 and the next few years in Southeast Asia

Total Market by Segment:

Southeast Asia Thrombolytic Therapy Market, By Type, 2015-2020, 2021-2026 ($ millions)
Southeast Asia Thrombolytic Therapy Market Segment Percentages, By Type, 2019 (%)

• Drug Treatment
• Surgical Treatment
• Other Treatment
• Drug treatment is the most commonly used type, with about 89.15% market share in 2019.

Southeast Asia Thrombolytic Therapy Market, By Application, 2015-2020, 2021-2026 ($ millions)
Southeast Asia Thrombolytic Therapy Market Segment Percentages, By Application, 2019 (%)

• Acute Myocardial Infarction
• Pulmonary Embolism
• Deep Vein Thrombosis
• Blocking the Catheter
• Acute Ischemic Stroke
• Demand from the acute myocardial infarction accounts for the largest market share, being 36.9% in 2019.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Thrombolytic Therapy Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Thrombolytic Therapy Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Boehringer Ingelheim
• Mochida Pharmaceutical
• NanJing Nanda Pharmaceutical
• Wanhua Biochem
• Tianjin Biochem Pharmaceutical
• Livzon Pharmaceutical Group
• Sedico Pharmaceuticals
• Microbix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thrombolytic Therapy Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 COVID-19 Impact: Southeast Asia Thrombolytic Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 SOUTHEAST ASIA THROMBOLYTIC THERAPY OVERALL MARKET SIZE

2.1 Southeast Asia Thrombolytic Therapy Market Size: 2020 VS 2026
2.2 Southeast Asia Thrombolytic Therapy Revenue, Prospects & Forecasts: 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Thrombolytic Therapy Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Thrombolytic Therapy Companies Ranked by Revenue
3.3 Southeast Asia Thrombolytic Therapy Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Thrombolytic Therapy Companies in Southeast Asia, by Revenue in 2019
3.5 Southeast Asia Manufacturers Thrombolytic Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thrombolytic Therapy Players in Southeast Asia
  3.6.1 List of Southeast Asia Tier 1 Thrombolytic Therapy Companies
  3.6.2 List of Southeast Asia Tier 2 and Tier 3 Thrombolytic Therapy Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Thrombolytic Therapy Market Size Markets, 2020 & 2026
  4.1.2 Drug Treatment
  4.1.3 Surgical Treatment
  4.1.4 Other Treatment
4.2 By Type - Southeast Asia Thrombolytic Therapy Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Thrombolytic Therapy Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Thrombolytic Therapy Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Thrombolytic Therapy Revenue Market Share, 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Thrombolytic Therapy Market Size, 2020 & 2026
  5.1.2 Acute Myocardial Infarction
  5.1.3 Pulmonary Embolism
  5.1.4 Deep Vein Thrombosis
  5.1.5 Blocking the Catheter
  5.1.6 Acute Ischemic Stroke
5.2 By Application - Southeast Asia Thrombolytic Therapy Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Thrombolytic Therapy Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Thrombolytic Therapy Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Thrombolytic Therapy Revenue Market Share, 2015-2026

6 PLAYERS PROFILES

6.1 Roche
  6.1.1 Roche Corporate Summary
  6.1.2 Roche Business Overview
  6.1.3 Roche Thrombolytic Therapy Major Product Offerings
  6.1.4 Roche Revenue in Southeast Asia (2015-2020)
  6.1.5 Roche Key News
6.2 Boehringer Ingelheim
  6.2.1 Boehringer Ingelheim Corporate Summary
  6.2.2 Boehringer Ingelheim Business Overview
  6.2.3 Boehringer Ingelheim Thrombolytic Therapy Major Product Offerings
  6.2.4 Boehringer Ingelheim Revenue in Southeast Asia (2015-2020)
  6.2.5 Boehringer Ingelheim Key News
6.3 Mochida Pharmaceutical
  6.3.1 Mochida Pharmaceutical Corporate Summary
  6.3.2 Mochida Pharmaceutical Business Overview
  6.3.3 Mochida Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.3.4 Mochida Pharmaceutical Revenue in Southeast Asia (2015-2020)
  6.3.5 Mochida Pharmaceutical Key News
6.4 NanJing Nanda Pharmaceutical
  6.4.1 NanJing Nanda Pharmaceutical Corporate Summary
  6.4.2 NanJing Nanda Pharmaceutical Business Overview
  6.4.3 NanJing Nanda Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.4.4 NanJing Nanda Pharmaceutical Revenue in Southeast Asia (2015-2020)
  6.4.5 NanJing Nanda Pharmaceutical Key News
6.5 Wanhua Biochem
  6.5.1 Wanhua Biochem Corporate Summary
  6.5.2 Wanhua Biochem Business Overview
  6.5.3 Wanhua Biochem Thrombolytic Therapy Major Product Offerings
  6.5.4 Wanhua Biochem Revenue in Southeast Asia (2015-2020)
  6.5.5 Wanhua Biochem Key News
6.6 Tianjin Biochem Pharmaceutical
  6.6.1 Tianjin Biochem Pharmaceutical Corporate Summary
  6.6.2 Tianjin Biochem Pharmaceutical Business Overview
  6.6.3 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.6.4 Tianjin Biochem Pharmaceutical Revenue in Southeast Asia (2015-2020)
  6.6.5 Tianjin Biochem Pharmaceutical Key News
6.7 Livzon Pharmaceutical Group
  6.6.1 Livzon Pharmaceutical Group Corporate Summary
  6.6.2 Livzon Pharmaceutical Group Business Overview
  6.6.3 Livzon Pharmaceutical Group Thrombolytic Therapy Major Product Offerings
  6.4.4 Livzon Pharmaceutical Group Revenue in Southeast Asia (2015-2020)
  6.7.5 Livzon Pharmaceutical Group Key News
6.8 Sedico Pharmaceuticals
  6.8.1 Sedico Pharmaceuticals Corporate Summary
  6.8.2 Sedico Pharmaceuticals Business Overview
  6.8.3 Sedico Pharmaceuticals Thrombolytic Therapy Major Product Offerings
  6.8.4 Sedico Pharmaceuticals Revenue in Southeast Asia (2015-2020)
  6.8.5 Sedico Pharmaceuticals Key News
6.9 Microbix
  6.9.1 Microbix Corporate Summary
  6.9.2 Microbix Business Overview
  6.9.3 Microbix Thrombolytic Therapy Major Product Offerings
  6.9.4 Microbix Revenue in Southeast Asia (2015-2020)
  6.9.5 Microbix Key News
6.10 Syner-Med
  6.10.1 Syner-Med Corporate Summary
  6.10.2 Syner-Med Business Overview
  6.10.3 Syner-Med Thrombolytic Therapy Major Product Offerings
  6.10.4 Syner-Med Revenue in Southeast Asia (2015-2020)
  6.10.5 Syner-Med Key News

7 KEY MARKET TRENDS & INFLUENCES 2021-2026

7.1 PESTLE Analysis for Southeast Asia Thrombolytic Therapy Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Thrombolytic Therapy in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Thrombolytic Therapy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Thrombolytic Therapy Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Thrombolytic Therapy Sales by Companies, (K Units), 2015-2020
Table 6. Southeast Asia Thrombolytic Therapy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Thrombolytic Therapy Price (2015-2020) (US$/Unit)
Table 8. Southeast Asia Manufacturers Thrombolytic Therapy Product Type
Table 9. List of Southeast Asia Tier 1 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Thrombolytic Therapy Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Thrombolytic Therapy Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Thrombolytic Therapy Sales in Southeast Asia (K Units), 2015-2020
Table 14. By Type - Thrombolytic Therapy Sales in Southeast Asia (K Units), 2021-2026
Table 15. By Application - Thrombolytic Therapy Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Thrombolytic Therapy Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Thrombolytic Therapy Sales in Southeast Asia, (K Units), 2015-2020
Table 18. By Application - Thrombolytic Therapy Sales in Southeast Asia, (K Units), 2021-2026
Table 19. Roche Corporate Summary
Table 20. Roche Thrombolytic Therapy Product Offerings
Table 21. Roche Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 22. Boehringer Ingelheim Corporate Summary
Table 23. Boehringer Ingelheim Thrombolytic Therapy Product Offerings
Table 24. Boehringer Ingelheim Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 25. Mochida Pharmaceutical Corporate Summary
Table 26. Mochida Pharmaceutical Thrombolytic Therapy Product Offerings
Table 27. Mochida Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 28. NanJing Nanda Pharmaceutical Corporate Summary
Table 29. NanJing Nanda Pharmaceutical Thrombolytic Therapy Product Offerings
Table 30. NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 31. Wanhua Biochem Corporate Summary
Table 32. Wanhua Biochem Thrombolytic Therapy Product Offerings
Table 33. Wanhua Biochem Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 34. Tianjin Biochem Pharmaceutical Corporate Summary
Table 35. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Product Offerings
Table 36. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 37. Livzon Pharmaceutical Group Corporate Summary
Table 38. Livzon Pharmaceutical Group Thrombolytic Therapy Product Offerings
Table 39. Livzon Pharmaceutical Group Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 40. Sedico Pharmaceuticals Corporate Summary
Table 41. Sedico Pharmaceuticals Thrombolytic Therapy Product Offerings
Table 42. Sedico Pharmaceuticals Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 43. Microbix Corporate Summary
Table 44. Microbix Thrombolytic Therapy Product Offerings
Table 45. Microbix Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 46. Syner-Med Corporate Summary
Table 47. Syner-Med Thrombolytic Therapy Product Offerings
Table 48. Syner-Med Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)

List Of Figures

LIST OF FIGURES

Figure 1. Thrombolytic Therapy Segment by Type
Figure 2. Thrombolytic Therapy Segment by Application
Figure 3. Southeast Asia Thrombolytic Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Thrombolytic Therapy Market Size in Southeast Asia, (US$, Mn): 2020 VS 2026
Figure 6. Southeast Asia Thrombolytic Therapy Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thrombolytic Therapy Revenue in 2019
Figure 8. By Type - Southeast Asia Thrombolytic Therapy Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - Southeast Asia Thrombolytic Therapy Market Share, 2015-2026
Figure 10. By Application - Thrombolytic Therapy Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 11. By Application - Southeast Asia Thrombolytic Therapy Market Share, 2015-2026
Figure 12. PEST Analysis for Southeast Asia Thrombolytic Therapy Market in 2020
Figure 13. Thrombolytic Therapy Market Opportunities & Trends in Southeast Asia
Figure 14. Thrombolytic Therapy Market Drivers in Southeast Asia